Jasdeep Sidhu
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,507 | 392 | 93.2% |
| Education | $615.79 | 8 | 6.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $953.67 | 35 | $0 (2023) |
| GENZYME CORPORATION | $584.48 | 14 | $0 (2024) |
| Incyte Corporation | $521.84 | 30 | $0 (2024) |
| BeiGene USA, Inc. | $500.97 | 11 | $0 (2024) |
| Seagen Inc. | $496.08 | 20 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $473.30 | 29 | $0 (2024) |
| Celgene Corporation | $426.65 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $391.77 | 19 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $353.40 | 22 | $0 (2024) |
| Daiichi Sankyo Inc. | $301.05 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,657 | 129 | Novartis Pharmaceuticals Corporation ($473.30) |
| 2023 | $1,950 | 95 | Seagen Inc. ($243.92) |
| 2022 | $1,669 | 81 | Amgen Inc. ($334.53) |
| 2021 | $2,398 | 82 | GENZYME CORPORATION ($528.84) |
| 2020 | $432.20 | 12 | Eisai Inc. ($104.75) |
| 2019 | $17.20 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($17.20) |
All Payment Transactions
400 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Deciphera Pharmaceuticals Inc. | QINLOCK (Drug) | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: Oncology | ||||||
| 12/13/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $21.01 | General |
| 12/12/2024 | SOBI, INC | SYNAGIS (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: IMMUNOLOGY | ||||||
| 12/10/2024 | Ipsen Biopharmaceuticals, Inc | Onivyde (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Oncology | ||||||
| 12/10/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $12.44 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: Oncology | ||||||
| 12/03/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: Hematology | ||||||
| 12/02/2024 | Incyte Corporation | PEMAZYRE (Drug), MONJUVI | Food and Beverage | Cash or cash equivalent | $27.85 | General |
| Category: Hepatology (Liver, Pancreatic, Gall Bladder) | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Oncology | ||||||
| 11/15/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $20.35 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Janssen Biotech, Inc. | TALVEY (Biological) | Food and Beverage | In-kind items and services | $21.97 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Rare Disease | ||||||
| 11/09/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Education | In-kind items and services | $86.99 | General |
| Category: ONCOLOGY | ||||||
| 11/09/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Oncology | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $26.42 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $9.50 | General |
| Category: Immunology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.79 | General |
| 11/04/2024 | Celgene Corporation | — | Food and Beverage | Cash or cash equivalent | $210.38 | General |
| 11/02/2024 | Siemens Medical Solutions USA, Inc. | Cios Spin (Device) | Food and Beverage | In-kind items and services | $26.45 | General |
| Category: AT - Mobile interventional x-ray/angiography fluoroscopy | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $26.13 | General |
| Category: Hematology/Oncology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 117 | 170 | $40,311 | $15,716 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 46 | 46 | $14,628 | $5,572 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 33 | 56 | $13,683 | $5,300 | 38.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 20 | 46 | $6,302 | $2,714 | 43.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 22 | $5,698 | $2,129 | 37.4% |
About Jasdeep Sidhu
Jasdeep Sidhu is a Student in an Organized Health Care Education/Training Program healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/24/2016. The National Provider Identifier (NPI) number assigned to this provider is 1760935910.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jasdeep Sidhu has received a total of $9,123 in payments from pharmaceutical and medical device companies, with $2,657 received in 2024. These payments were reported across 400 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($8,507).
As a Medicare-enrolled provider, Sidhu has provided services to 117 Medicare beneficiaries, totaling 170 services with total Medicare billing of $15,716. Data is available for 1 year (2023–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Hematology & Oncology
- Location Louisville, KY
- Active Since 07/24/2016
- Last Updated 06/05/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1760935910
Products in Payments
- BRUKINSA (Drug) $500.97
- JAKAFI (Drug) $327.36
- LIBTAYO (Biological) $319.25
- OPDIVO (Biological) $296.24
- IMBRUVICA (Drug) $270.49
- Lenvima (Drug) $266.07
- LUMAKRAS (Drug) $250.37
- Enhertu (Drug) $202.12
- GILOTRIF (Drug) $190.66
- KEYTRUDA (Biological) $189.66
- Trodelvy (Drug) $159.37
- VENCLEXTA (Drug) $158.66
- ADCETRIS (Biological) $156.34
- MONJUVI (Drug) $152.87
- Fabhalta (Drug) $152.41
- PADCEV (Biological) $142.06
- Nplate (Biological) $139.91
- INLYTA (Drug) $132.18
- SARCLISA (Biological) $131.79
- Tavalisse (Drug) $122.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Louisville
Mr. John Lewis, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $1.2M
Mr. Martin Gnoni, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $138,860
Samantha Baah, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $127,608
Dr. Jeremy Clark, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $108,698
Timothy Dawson, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $54,598
Shawn Adams, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $47,553